Patent Foramen Ovale: Closing the Gap of Indications for Closure-Time for a Patient-Tailored Therapy
- PMID: 33303112
- DOI: 10.1016/j.jcin.2020.10.038
Patent Foramen Ovale: Closing the Gap of Indications for Closure-Time for a Patient-Tailored Therapy
Keywords: PFO closure; patent foramen ovale; thrombophilia.
Conflict of interest statement
Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure.JACC Cardiovasc Interv. 2020 Dec 14;13(23):2745-2752. doi: 10.1016/j.jcin.2020.09.059. JACC Cardiovasc Interv. 2020. PMID: 33303111 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous